<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:admin="http://webns.net/mvcb/"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:media="http://search.yahoo.com/mrss/">
<channel>

<title>Blogosm &#45; Himanshu Mason</title>

<!-- FIX -->
<link>https://blogosm.com/rss/author/himanshu-mason</link>

<description>Blogosm &#45; Himanshu Mason</description>
<dc:language>en</dc:language>

<dc:rights>Copyright 2020 to 2026 Blogosm &#45; All Rights Reserved.</dc:rights>



<item>

<title>AACR 2025: A Leap Toward Precision Oncology—DelveInsight’s Insightful Breakdown</title>

<link>https://blogosm.com/aacr-2025-a-leap-toward-precision-oncologydelveinsights-insightful-breakdown</link>

<guid>https://blogosm.com/aacr-2025-a-leap-toward-precision-oncologydelveinsights-insightful-breakdown</guid>

<description><![CDATA[ The AACR Conference Coverage 2025 by DelveInsight offers an in-depth look at the latest advancements and discoveries presented at the American Association for Cancer Research (AACR) Annual Meeting 2025. As one of the most prestigious cancer research conferences globally, the AACR 2025 conference attracts leading scientists, oncologists, pharmaceutical companies, and patient advocacy organizations, all aiming to accelerate progress in the fight against cancer. ]]></description>


<pubDate>Thu, 13 Mar 2025 12:52:58 +0530</pubDate>

<dc:creator>Himanshu Mason</dc:creator>

<media:keywords>aacr, aacr2025</media:keywords>


</item>


<item>

<title>Rezdiffra Breakthrough: Madrigal&amp;apos;s Game&#45;Changer for Non&#45;Alcoholic Steatohepatitis</title>

<link>https://blogosm.com/rezdiffra-breakthrough-madrigals-game-changer-for-non-alcoholic-steatohepatitis</link>

<guid>https://blogosm.com/rezdiffra-breakthrough-madrigals-game-changer-for-non-alcoholic-steatohepatitis</guid>

<description><![CDATA[ However, the Rezdiffra price in the USA will be a key factor in determining how widely accessible the treatment will be. ]]></description>


<pubDate>Sun, 09 Mar 2025 23:23:07 +0530</pubDate>

<dc:creator>Himanshu Mason</dc:creator>

<media:keywords>rezdiffra, breakthrough, madrigal, game, changer, non, alcoholic, steatohepatitis</media:keywords>


</item>


</channel>
</rss>